Loading clinical trials...
Loading clinical trials...
This is a single site, prospective, non-blinded, non-randomized, before/after study. This study is designed to evaluate the impact of monitoring and reversal guidelines for neuromuscular blocking drug...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
University of California, Davis
NCT06962007 · Neuromuscular Blockade Reversal Agent, Perioperative Complications, and more
NCT06623370 · Sugammadex Reversal Time, Muscle Weakness
NCT05708469 · Sugammadex, Pregnant, Anesthesia
NCT04997759 · Sugammadex
NCT05066035 · Neuromuscular Blockade, Sugammadex, and more
UC Davis Medical Center
Sacramento, California
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions